- On Wednesday, November 14, 2012, Celgene will present at the Credit Suisse Healthcare Conference at 5:30 p.m. ET.
- On Tuesday, November 27, 2012, Celgene will present at the Piper Jaffray 24 th Annual Healthcare Conference at 9:00 a.m. ET.
Gilead is under enormous pressure from investors to acquire companies or develop new drugs from its pipeline.
Celgene is not some dinky micro-cap biotech lacking the resources or knowledge to conduct a rigorous clinical trial, so omitting a placebo arm from the GED-0301 study is inexcusable.